Literature DB >> 24854380

Large-vessel involvement in giant cell arteritis and polymyalgia rheumatica.

Francesco Muratore1, Giulia Pazzola, Nicolò Pipitone, Luigi Boiardi, Carlo Salvarani.   

Abstract

Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are closely related disorders that affect people of middle age and older, and frequently occur together. With the widespread use of newer vascular imaging modalities, large-vessel involvement (LVI) has increasingly been recognised in patients with GCA and less often in those with PMR. LVI in GCA can result in complications such as aortic aneurysm and dissection, aortic arch syndrome, and limb arteries stenosis, while vascular complications in PMR are exceedingly rare. It is still controversial which patients should be investigated for LVI, and how LVI should be diagnosed, monitored and managed. In this review, we will try to address six important issues regarding LVI in GCA and PMR.

Entities:  

Mesh:

Year:  2014        PMID: 24854380

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  9 in total

1.  Baseline clinical predictors of an ultimate giant cell arteritis diagnosis in patients referred to temporal artery biopsy.

Authors:  Chagai Grossman; Iris Barshack; Nira Koren-Morag; Ilan Ben-Zvi; Gil Bornstein
Journal:  Clin Rheumatol       Date:  2016-03-01       Impact factor: 2.980

Review 2.  Giant cell arteritis and polymyalgia rheumatica: an update.

Authors:  Miguel A González-Gay; Trinitario Pina
Journal:  Curr Rheumatol Rep       Date:  2015-02       Impact factor: 4.592

3.  Glucocorticoid usage in giant cell arteritis over six decades (1950 to 2009).

Authors:  A Chandran; Pr D Udayakumar; T A Kermani; K J Warrington; C S Crowson; E L Matteson
Journal:  Clin Exp Rheumatol       Date:  2015-05-26       Impact factor: 4.473

Review 4.  An Updated Review of Cardiovascular Events in Giant Cell Arteritis.

Authors:  Hubert de Boysson; Achille Aouba
Journal:  J Clin Med       Date:  2022-02-15       Impact factor: 4.241

5.  Negative temporal artery biopsy: predictive factors for giant cell arteritis diagnosis and alternate diagnoses of patients without arteritis.

Authors:  Gil Bornstein; Iris Barshack; Nira Koren-Morag; Ilan Ben-Zvi; Nadav Furie; Chagai Grossman
Journal:  Clin Rheumatol       Date:  2018-03-17       Impact factor: 2.980

6.  Cryptococcal Meningitis in A Patient With Giant Cell Arteritis.

Authors:  Jin Lv; Qiankun Zhang
Journal:  Arch Rheumatol       Date:  2017-04-04       Impact factor: 1.472

Review 7.  Linking classification and therapeutic management of vasculitides.

Authors:  Corisande Baldwin; Simon Carette; Christian Pagnoux
Journal:  Arthritis Res Ther       Date:  2015-06-02       Impact factor: 5.156

Review 8.  Giant cell arteritis: is the clinical spectrum of the disease changing?

Authors:  Miguel Á González-Gay; Miguel Ortego-Jurado; Liliana Ercole; Norberto Ortego-Centeno
Journal:  BMC Geriatr       Date:  2019-07-29       Impact factor: 3.921

9.  Distribution patterns of arterial affection and the influence of glucocorticoids on 18F-fluorodeoxyglucose positron emission tomography/CT in patients with giant cell arteritis.

Authors:  Martin Freesmeyer; Alexander Pfeil; Leander Malich; Falk Gühne; Tobias Hoffmann; Ansgar Malich; Tobias Weise; Peter Oelzner; Gunter Wolf
Journal:  RMD Open       Date:  2022-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.